Manros Therapeutics
Roscoff, Bretagne, France
About Manros Therapeutics
ManRos Therapeutics was founded in 2007 by Dr. Laurent Meijer (EC Director of Research, CNRS) and Pr. Hervé Galons (EC Professor, Université Paris-Descartes), two leading specialists in cellular and molecular biology and in organic chemistry, respectively. The objectives of ManRos Therapeutics are the identification, characterization, optimization (medicinal chemistry) and preclinical & clinical development of pharmacological kinase inhibitors (some derived from marine natural products) for their use in the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer’s disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Dec 2008)
- Website: manros-therapeutics.com
- Phone: +33 (0)2 98 72 59 67
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/manros-therapeutics-2584341 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.